Jasmine Shantelle Burns, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 15484 Jost Main St, Florissant, MO 63034 Phone: 314-458-9525 |
Mrs. Brenda L Grant, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4585 Washington St, Suite A-4, Florissant, MO 63033 Phone: 314-402-4693 |
Ms. Yolonda Marchelle Mckinnies, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3815 Woodcrest Dr, Florissant, MO 63033 Phone: 314-922-1172 Fax: 314-830-2328 |
Quonisha Hollie, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3932 Arbre Ln, Florissant, MO 63034 Phone: 314-285-1049 |
Ebony Wagner, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2325 Patterson Rd, Florissant, MO 63031 Phone: 314-620-5553 Fax: 314-584-5002 |
Sharon Denise Cox, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4045 Ashbury Crossings Dr, Florissant, MO 63034 Phone: 314-550-7651 |
Keri Mcgill, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 16727 N Fork Ridge Dr, Florissant, MO 63034 Phone: 314-922-6174 |
Ayanna Washington, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1150 Graham Rd Ste 102, Florissant, MO 63031 Phone: 314-206-3900 |
Jassma Davis, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 660 Jamaica Pl, Florissant, MO 63033 Phone: 314-643-3413 |
Samantha Shanks, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 224 N Highway 67 St, Suite 231, Florissant, MO 63031 Phone: 636-344-9357 |
News Archive
Men are twice as likely as women to develop Parkinson's disease, a nervous system disorder characterized by tremors and difficulty moving. New research to be presented at Cardiovascular, Renal and Metabolic Diseases: Physiology and Gender suggests that the difference in risk may be due to the presence of the male sex hormone testosterone.
Oxagen Limited, a drug discovery and development company specializing in inflammation, today announced that the recruitment for its double blind, randomised, placebo controlled Phase IIb clinical trial in asthma with OC000459, its lead oral CRTH2 (DP2) antagonist, has now been completed.
Today AbbVie announced the European Commission granted marketing authorization for IMBRUVICA (ibrutinib) as the first treatment option available in all 28 member states of the European Union for the treatment of Waldenstrom's macroglobulinemia (WM), a rare, slow growing blood cancer, in adult patients who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.
Secretary of Health Everette James today urged all Pennsylvanians to ensure they are fully immunized against vaccine-preventable diseases, noting that August is National Immunization Awareness Month.
Exercise promotes heart health. However, many lifestyle factors cause heart disease, and regular activity may not be enough to prevent heart attacks. A new study in the American Journal of Physiology-Heart and Circulatory Physiology expands on the heart benefits of exercise, investigating whether regular exercise still helps the heart even after a heart attack occurs.
› Verified 9 days ago